FDA Approves Unknown Drug — GLAXOSMITHKLINE
# FDA Approves GlaxoSmithKline Drug (NDA 018342) GlaxoSmithKline has received FDA approval for a new drug application, marking an expansion of the company's pharmaceutical portfol…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
# FDA Approves GlaxoSmithKline Drug (NDA 018342) GlaxoSmithKline has received FDA approval for a new drug application, marking an expansion of the company's pharmaceutical portfol…
# FDA Approval Newswire AbbVie Inc.'s DEPAKOTE (divalproex sodium) received FDA approval on March 10, 1983, establishing a foundational anticonvulsant therapy that would capture s…
# FDA Approves Methadone Hydrochloride Oral Formulation for Hikma Pharmaceuticals Hikma Pharmaceuticals USA Inc. received FDA approval for its oral methadone hydrochloride formula…
SUN PHARM INDUSTRIES announced FDA approval for ANDA087794, a regulatory milestone expected to bolster its product portfolio and support market share growth in the generic sector.
The FDA has confirmed the approval of Marlex Pharmaceuticals' oral furosemide product, supporting a staple in acute treatment protocols. While not a novel molecule, broadening the …
PAI Holdings, LLC dba PAI Pharma secured FDA approval for its Acetaminophen and Codeine Phosphate oral generic, strengthening the company’s position in the prescription pain manage…
Pharmobedient has announced approval for its ANDA submission, a milestone expected to drive market expansion for its generic product portfolio.
Hikma Pharmaceuticals USA Inc. announced this morning that the FDA approved a supplemental ANDA for Methadone Hydrochloride Oral Solution, a generic form of the abused narcotic. Th…
# FDA Approves ICU Medical's Lactated Ringer's Solution, Expanding Critical Care Portfolio ICU Medical, Inc. has received FDA approval for Ringers (sodium chloride, potassium chlo…
HIKMA is positioned to bolster its market share following the FDA's approval of ANDA087003, a move expected to expand revenue streams as the generic enters the competitive landscap…
Sun Pharmaceutical Industries Ltd received FDA approval for an Abbreviated New Drug Application, a milestone that is poised to enhance the company's market revenue and expand its p…
Sun Pharma Industries Ltd. obtained FDA approval for Abbreviated New Drug Application 085868, marking a key regulatory advancement for a new generic product. This clearance is expe…
Actavis Mid Atlantic received FDA approval for a generic medication via ANDA #085861, strengthening its market position to capitalize on growth opportunities and competitor pricing…
OZANTRI has solidified its market position in the pharmaceutical sector following the FDA's confirmation of its regulatory status via the benchmark ANDA 085106 filing, a move that …
# FDA Approves Organon's SINEMET (Carbidopa and Levodopa) for Oral Administration Organon LLC's approval of SINEMET, a combination of carbidopa and levodopa, represents a signific…
FDA approved IMPAX LABS' Abbreviated New Drug Application (ANDA060469) on July 13, 1971, giving the company regulatory clearance to manufacture a generic version of an un-named blo…
Baxter Healthcare Corporation’s continued FDA validation of its Dextrose Monohydrate product reinforces the manufacturer’s dominant position in the intravenous nutrition market, en…
# FDA Approves PRAGMA Drug; Expands Treatment Options in Growing Pharmaceutical Market PRAGMA has received FDA approval for a new therapeutic agent, marking the company's entry in…
Novartis announced FDA approval of a new formulation of its 1968-era anesthetic, a move the company says will modernize the treatment landscape by improving efficacy and safety, th…
Strides Pharma Intl has received FDA clearance for the new application via NDA008085, which is expected to bolster the company's market revenue through expanded portfolio capabilit…